A case of dystrophic Epidermolysis bullosa improved with etanercept for concomitant psoriatic arthritis

American Journal of Clinical Dermatology

Volumn 11, Issue SUPPL. 1, 2010, Pages 53-54

  Gubinelli, Emanuela ^a   Angelo, Corrado ^a   Pacifico, Valeria ^a  

^a LABORATORIO DI PATOLOGIA VASCOLARE   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

ETANERCEPT; NONSTEROID ANTIINFLAMMATORY AGENT; SULFALAZINE; TUMOR NECROSIS FACTOR ALPHA;

ADULT; ARTHRALGIA; ARTICLE; CASE REPORT; CORRELATION ANALYSIS; DRUG WITHDRAWAL; ENTHESOPATHY; EPIDERMOLYSIS BULLOSA DYSTROPHICA; ERYTHEMA; FEMALE; HUMAN; INTERPHALANGEAL JOINT; METACARPOPHALANGEAL JOINT; NUCLEAR MAGNETIC RESONANCE IMAGING; PATHOGENESIS; PHYSICAL EXAMINATION; PRIORITY JOURNAL; PRURITUS; PSORIASIS SEVERITY INDEX; PSORIATIC ARTHRITIS; TREATMENT DURATION;

ADULT; ARTHRITIS, PSORIATIC; EPIDERMOLYSIS BULLOSA DYSTROPHICA; FEMALE; HUMANS; IMMUNOGLOBULIN G; IMMUNOLOGIC FACTORS; RECEPTORS, TUMOR NECROSIS FACTOR; TREATMENT OUTCOME; TUMOR NECROSIS FACTOR-ALPHA;

EID: 77954268501     PISSN: 11750561     EISSN: 11791888     Source Type: Journal    
DOI: 10.2165/1153427-S0-000000000-00000     Document Type: Article

References (3)

1. Fine JD, Johnson LB, Weiner M, et al. Epidermolysis bullosa and the risk of life-threatening cancers: the National EB Registry experience, 1986-2006. J Am Acad Dermatol 2009;60:203-11
2. Chopra V, Tyring SK, Johnson L, et al. Patients with severe forms of inherited epidermolysis bullosa exhibit decreased lymphokine and monokine production. J Clin Immunol 1990;10:321-9
3. Chopra V, Tyring SK, Johnson L, et al. Peripheral blood mononuclear cell subsets in patients with severe inherited forms of epidermolysis bullosa. Arch Dermatol 1992;128:201-9